Margins to remain in mid 15% range for FY 16E, increase in FY 17E on operating leverage

Size: px
Start display at page:

Download "Margins to remain in mid 15% range for FY 16E, increase in FY 17E on operating leverage"

Transcription

1 January 29, 2016 Buy Maruti Suzuki (MSIL) Industry: Auto and Auto Components Industry View: Positive Result Update Prune estimates on margin dip, maintain BUY on good volume growth Q3 numbers hurt by slurry of unexpected costs Maruti Suzuki India Ltd (MSIL) s Q3FY16 numbers came in well below street expectations. The top-line grew by 20% yoy at Rs148 bn. Volumes in the quarter grew by 15.6% yoy and 6% qoq to 3.74 lakh units. Net realizations improved by 5.9% yoy and 2.7% qoq as the quarter saw high priced new launches. EBITDA grew by 31% yoy while EBITDA margins decreased from 16.7% to 14.7% qoq. RM to sales went up to 69.9% up from 68.6% qoq due to decretion of inventory levels at 4,000 units from an average of 25,000 units. Employee costs increased to 3.42% from 3.08% qoq on higher bonus expenses which led to an impact of 15 bps on margins. Other expenses were at 14.1% due to Rs 700 mn additional costs linked with maintenance of the ageing Gurgaon plant which the company carries out biannually (June and December). Also the launch costs associated with Baleno and S-Cross led to higher advertising expenses. Furthermore, discounts associated with S-Cross (~Rs 2 lakh per vehicle) also led to margin dip. Other income remained low due to low scrap sale rate, while depreciation and amortization sequentially grew by 8% and 15% yoy to Rs 7.2 bn on the back of new launches. Tax rate in the quarter went up to 29.9%. In line with weak operational outperformance adjusted PAT dropped by 17% qoq at Rs10.19 bn, but grew by 17% yoy. MSIL volumes to spur on new launches though small cars are facing competition Currently the demand for passenger vehicles has been picking up. MSIL has posted a 13.9% domestic growth in Q3FY16. With MSIL s wide distribution network, robust aftersales support, wide portfolio of affordable products and recent good launches, MSIL has reported strong domestic numbers. Demand has shifted more towards petrol vehicles with the gap between diesel and petrol getting narrower day by day (68% petrol v/s 32% diesel). With new products such as Ciaz, S-Cross and Baleno, MSIL has been able to grow its overall PV market share though competition has stiffened. In the hatchback small car segment, the launch of Renault Kwid is gving very tough competition to the likes of Alto (growth of just 0.5% YTD). With Ciaz continuing a strong show in the third quarter of its launch, we expect this car to be the front runner in sedan segment for MSIL alongside Dzire. We are optimistic about the volume growth here on considering the warm response for Ciaz, new launch of Swift variant, Celerio strength, and the recent launch of Baleno which is attracting demand of units per month. Since the launch of Baleno happened in Q3, the complete full year volumes numbers of it will be seen only in FY17, which we believe to take MSIL s volumes to an altogether new level. We estimate 8% of sales to come from Baleno in FY17 (1,20,000 units). The forthcoming Auto Expo will witness MSIL showcasing two new models. The first one to be launched is Vitarra Brezza SUV to compete with Hyundai Creta, Mahindra TUV 3oo, Renault Duster and Ford Ecosport while the second launch is of Ignis, which will be pitted in against the likes of Mahindra KUV 100. The launches will follow in Q4 or Q1FY17. Stock Data Current Market Price (Rs) 4,040 Target Price (Rs) 4,486 Potential upside (%) 11 Reuters Bloomberg What s Changed MRTI.BO MSIL IN 12 month PriceTarget (Rs) From 4,891 to 4,486 FY2016E EPS (Rs) From 180 to 160 FY2017E EPS (Rs) From 222 to 214 Key Data Market Cap (Rs bn) 1, Week Range (Rs) 4,789 / 3,362 Avg Daily Trading Value last 6 mts(rs.mn) 3,393 Promotors (%) FII Holding (%) DII Holding (%) Public & Others Holding (%) 6.29 Fiscal YE YE Mar FY14 FY15 FY16E FY17E Total sales (Rs bn) EBITDA margins(%) PAT margins(%) EPS P/E P/BV EV/EBITDA ROE% ROCE% Dividend yield % Relative Price Performance Jan-15 May-15 Sep-15 Jan-16 Maruti Suzuki One Year Indexed S&P Bse Sensex (%) 1 Month 3 Months 12 Months Absolute (12) (9) 10 BSE Relative (6) 1 27 Ashwin Patil [email protected] Disclaimer: The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true and is for general guidance only. While every effort is made to ensure the accuracy and completeness of information contained, the company makes no guarantee and assumes no liability for any errors or omissions of the information. No one can use the information as the basis for any claim, demand or cause of action. LKP Securities Ltd., and affiliates, including the analyst who have issued this report, may, on the date of this report, and from time to time, have long or short positions in, and buy or sell the securities of the companies mentioned herein or engage in any other transaction involving such securities and earn brokerage or compensation or act as advisor or have other potential conflict of interest with respect to company/ies mentioned herein or inconsistent with any recommendation and related information and opinions. LKP Securities Ltd., and affiliates may seek to provide or have engaged in providing corporate finance, investment banking or other advisory services in a merger or specific transaction to the companies referred to in this report, as on the date of this report or in the past.

2 Financial Highlights Maruti Suzuki India Ltd. If the monsoon this year is in line with expectations then the rural markets (>30% of total volumes) also may yield a good traction for MSIL. Considering the growth that the company has posted in 9M FY16 at 13.9%, we believe that with the recent launches, the company can easily post a growth of 13.1% in FY16E and 14.9% in FY17E on an additional boost from the newer launches. On the exports front, we expect growth to continue from geographies like Angola, Peru, Chile, Indonesia, Algeria etc. MSIL has also started exporting Baleno to markets like Japan which will provide a fillip to exports. We expect exports to grow at 6%/8% in FY16E/17E. Margins to remain in mid 15% range for FY 16E, increase in FY 17E on operating leverage Q3 EBITDA margins were badly hit by some unforeseen costs related with inventory decretion, employee bonus costs and maintenance costs at Gurgaon plant. However, higher discounting and new launch expenses were factored in the street estimates. Commodity costs benefits were seen in the quarter to the extent of 50 bps only but going forward these benefits will be limited. The increase in the opening of Nexa outlets (200 by end of FY17 from 100 currently) along with higher foreign import content in Baleno as well as the upcoming launches of Brezza and Ignis may continue to impact margins in Q4 and in FY17E. Almost 21% of the RM costs are Yen denominated (6% royalty and 16% indirect imports at vendor end). However, the concerns over appreciating Yen v/s Rupee are mitigated in Q4 as the company has taken hedges against it. Also, with increase in Baleno exports to Japan the company will be awarded with a natural hedge. However, the indirect imports will be impacted to the extent of GBP denominated imports as the company has unhedged exposure against GBP on the vendor side. New launches may provide us with a tradeoff between volume growth and marketing expenses escalation which may impact margins either ways. We also believe that prudent costs saving through internal processes and operating leverage coming in through new launches and volume growth also coming from Seventh Pay Commission implementation will provide margin boost. Considering the pros and cons, we have reduced FY16E margins to 15.5% from 16% and FY17E margins to 16.4% from 16.8% earlier. Rs mn Q3 FY16 Q2 FY16 % qoq Q3 FY15 % yoy Total income 150, , , Raw material costs 103,277 93, , Employee costs 5,045 4, , Other expenses 20,796 19, , EBITDA 21,701 22,694 (4.4) 16, EBITDA margins % 14.7% 16.7% (200 bps) 13.6% 110 bps Depreciation & Amortization 7,221 6, , Interest expenses (18.7) Other income 315 1,371 (77.0) 1,290 (75.6) PBT 14,551 17,193 (15.4) 11, Tax 4,358 4,937 (11.7) 2, Adjusted PAT 10,193 12,256 (16.8) 8, Exceptional items - - N/A 700 N/A Reported PAT (Rs) 10,193 12,256 (16.8) 8, LKP Research 2

3 Outlook and Valuation Maruti Suzuki India MSIL s volume performance has been very strong in 9M FY16 and the company has witnessed a quick gain in its market share too. With expectations of economic revival coming in FY17 along with interest rates and fuel costs going down along with recent launches of Baleno, S-Cross and Ciaz and upcoming launches of Brezza and Ignis from MSIL s stable will continue with a strong volume growth. Implementation of Seventh Pay Commission, improvement in GDP in line with falling oil prices and possible implementation of GST in FY17 will help the cause. MSIL being a proxy to the recovery in economy, we believe policy reforms and a populous upcoming budget may spur demand for cars. However, margin headwinds may lead to eating up of some gains coming from volume surge. Competition coming from Renault Kwid may impact Alto volumes, while Baleno and the upcoming launches which are expected to have high import content will be vulnerable to currency movement in Yen beyond Q4FY16 (where the Yen exposure is hedged). However, Baleno exports to Japan may provide a natural hedge in FY17 which is positive and would take care of much of the Yen exposure, though movement in GBP and $ exposures in indirect imports may impact margins. New launches of Brezza and Ignis may lead to increase advertising expenses. Lower commodity benefits may not restrict RM costs from moving higher but according to us the decretion of inventory levels seen in Q3 is a temporary phenomenon and will get adjusted in the ensuing quarters thus helping margins to improve from the lows seen in Q3. Higher capex and maintenance costs at the ageing Gurgaon plant may lead to higher depreciation costs, but expectations of higher other income and lower tax rate (24%) due to changes in accounting standards from FY17 may lift the bottomline. Expectations of higher exports with Baleno and newer launches to country like Japan may too help the profitability. In line with strong volume performance we have increased the volume outlook slightly but have cut the margin outlook to a higher extent than the volume upgradation. As a net-net effect, we have cut the target price by 8%, but from current levels, we still have an upside of 10% for a lower target price of 4,486. Maintain BUY. Per unit parameters (Rs.) Q4 FY14 Q1 FY15 Q2 FY15 Q3 FY15 Q4 FY15 Q1 FY16 Q2 FY16 Q3 FY16 Net Realisation/unit 363, , , , , , , ,666 Material Cost/unit 273, , , , , , , ,007 Employee cost per unit 12,344 11,788 11,489 11,578 14,658 13,567 11,830 13,483 EBITDA/unit 38,400 44,285 47,246 51,329 62,423 66,479 64,227 57,996 PAT/unit 24,626 25,414 26,795 26,927 37,041 37,293 34,685 27,241 LKP Research 3

4 Maruti Suzuki India Ltd. Financial Income statement YE Mar (Rs.mn) FY14 FY15 FY16E FY17E Total Revenues 436, , , ,668 Raw Material Cost 313, , , ,155 Employee Cost 13,681 16,066 20,061 22,095 Other Exp 59,221 66,431 81,903 96,764 EBITDA 50,151 67,130 90, ,655 EBITDA Margin(%) Other Income 8,229 8,316 5,000 6,000 Depreciation 20,844 24,703 27,713 29,834 EBIT 37,536 50,742 68,062 86,821 EBIT Margin(%) Interest PBT 35,777 48,682 67,062 86,021 PBT Margin(%) Tax 8,755 11,570 18,777 21,505 PAT 27,022 37,112 48,284 64,516 PAT Margins (%) Minority interest Exceptional items Adj PAT 27,022 37,112 48,284 64,516 Adj PAT Margins (%) Key Ratios YE Mar (Rs mn) FY14 FY15 FY16E FY17E Per Share Data (Rs) Adj. EPS CEPS BVPS DPS Growth Ratios(%) Total revenues EBITDA PAT EPS Growth Valuation Ratios (X) PE P/CEPS P/BV EV/Sales EV/EBITDA Operating Ratios (Days) Inventory days Recievable Days Payables day Net Debt/Equity (x) Profitability Ratios (%) ROCE ROE Dividend payout Dividend yield Source: Company, LKP Research Balance sheet YE Mar (Rs. mn) FY14 FY15 FY16E FY17E Equity and Liabilities Equity Share Capital 1,510 1,510 1,510 1,510 Reserves & Surplus 208, , , ,452 Total Networth 209, , , ,962 Total debt 4,604 1, Net Deferred Tax 5,866 4,810 3,810 2,810 Other long term liabilities 2,386 1, Long term provisions 1,980 2,926 3,426 3,926 Current Liab & Prov Short term borrowings 12, Other current liabilities 13,382 18,658 20,658 22,658 Trade payables 48,975 55,614 68,921 79,717 Total provisions 6,777 13,604 15,604 17,604 Total Equity & Liabilities 305, , , ,879 Assets Net block 106, , , ,123 Capital WIP 26,214 18,828 20,000 22,000 Intangible Assets 1,827 2,923 4,000 5,000 Non current Investments 13,048 98, , ,176 Other non current assets Total fixed assets Current investments 88,131 29,964 41,964 53,964 Cash and Bank 6, , Inventories 17,059 26,150 28,500 35,000 Trade receivables 14,137 10,698 11,220 11,123 Loan, Advances & others 12,511 11,728 18,136 22,330 Other current assets 3,779 3,256 3,510 4,060 Total current Assets 141,914 81, , ,588 Total Assets 305, , , ,879 Cash Flow YE Mar (Rs mn) FY14 FY15 FY16E FY17E PBT 36,585 48,682 67,062 86,021 Depreciation 20,844 24,703 27,713 29,834 Interest (510) 974 1, Chng in working capital 7,561 8,356 (4,081) (8,351) Tax paid (8,320) (10,407) (18,777) (21,505) Other operating activities (7,125) (8,202) (4,989) (6,000) Cash flow from operations (a) 49,035 64,106 67,928 80,798 Capital expenditure (34,984) (32,468) (51,172) (67,000) Chng in investments (25,893) (20,271) (5,000) (5,000) Other investing activities 11,948 7,740 1,864 1,000 (Inc)/dec inintangible assets 0 0 (1,077) (1,000) (Inc)/dec in other non curr. assets 9,457 5,682 2,941 2,000 Cash flow from investing (b) (48,929) (44,999) (54,308) (71,000) Free cash flow (a+b) ,107 13,620 9,798 Equity raised/(repaid) Inc/dec in borrowings 12, (500) (300) Dividend paid (incl. tax) (2,828) (4,241) (9,280) (11,600) Other financing activities (10,078) (15,734) (1,000) (800) Cash flow from financing (c) (659) (19,621) (10,780) (12,700) Net chng in cash (a+b+c) (553) (514) 2,840 (2,902) Closing cash & cash equiv , LKP Research 4

5 Maruti Suzuki India Ltd. DISCLAIMERS AND DISCLOSURES LKP Sec. ltd. (CIN-U67120MH1994PLC080039, www. Lkpsec.com) and its affiliates are a full-fledged, brokerage and financing group. LKP was established in 1992 and is one of India's leading brokerage and distribution house. LKP is a corporate trading member of Bombay Stock Exchange Limited (BSE), National Stock Exchange of India Limited(NSE), MCX Stock Exchange Limited (MCX-SX).LKP along with its subsidiaries offers the most comprehensive avenues for investments and is engaged in the businesses including stock broking (Institutional and retail), merchant banking, commodity broking, depository participant, insurance broking and services rendered in connection with distribution of primary market issues and financial products like mutual funds etc. LKP hereby declares that it has not defaulted with any stock exchange nor its activities were suspended by any stock exchange with whom it is registered in last five years. However, SEBI and Stock Exchanges have conducted the routine inspection and based on their observations have issued advice letters or levied minor penalty on LKP for certain operational deviations in ordinary/routine course of business. LKP has not been debarred from doing business by any Stock Exchange / SEBI or any other authorities; nor has its certificate of registration been cancelled by SEBI at any point of time. LKP offers research services to clients. The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. Other disclosures by LKP and its Research Analyst under SEBI (Research Analyst) Regulations, 2014 with reference to the subject company(s) covered in this report-: Research Analyst or his/her relative s financial interest in the subject company. (NO) LKP or its associates may have financial interest in the subject company. LKP or its associates and Research Analyst or his/her relative s does not have any material conflict of interest in the subject company. The research Analyst or research entity (LKP) has not been engaged in market making activity for the subject company. LKP or its associates may have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of Research Report. Research Analyst or his/her relatives have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of Research Report: (NO) LKP or its associates may have received any compensation including for investment banking or merchant banking or brokerage services from the subject company in the past 12 months. LKP or its associates may have received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. LKP or its associates may have received any compensation or other benefits from the Subject Company or third party in connection with the research report. Subject Company may have been client of LKP or its associates during twelve months preceding the date of distribution of the research report and LKP may have co-managed public offering of securities for the subject company in the past twelve months. Research Analyst has served as officer, director or employee of the subject company: (NO) LKP and/or its affiliates may seek investment banking or other business from the company or companies that are the subject of this material. Our salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that may be inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of the foregoing, among other things, may give rise to real or potential conflicts of interest including but not limited to those stated herein. Additionally, other important information regarding our relationships with the company or companies that are the subject of this material is provided herein. This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would subject LKP or its group companies to any registration or licensing requirement within such jurisdiction. Specifically, this document does not constitute an offer to or solicitation to any U.S. person for the purchase or sale of any financial instrument or as an official confirmation of any transaction to any U.S. person. Unless otherwise stated, this message should not be construed as official confirmation of any transaction. No part of this document may be distributed in Canada or used by private customers in United Kingdom. All trademarks, service marks and logos used in this report are trademarks or registered trademarks of LKP or its Group Companies. The information contained herein is not intended for publication or distribution or circulation in any manner whatsoever and any unauthorized reading, dissemination, distribution or copying of this communication is prohibited unless otherwise expressly authorized. Please ensure that you have read Risk Disclosure Document for Capital Market and Derivatives Segments as prescribed by Securities and Exchange Board of India before investing in Indian Securities Market. In so far as this report includes current or historic information, it is believed to be reliable, although its accuracy and completeness cannot be guaranteed. All material presented in this report, unless specifically indicated otherwise, is under copyright to LKP. None of the material, nor its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of LKP LKP Securites Ltd, 13th Floor, Raheja Center, Free Press Road, Nariman Point, Mumbai Tel Fax

Outlook and valuation

Outlook and valuation February 9, 2016 Neutral Bajaj Auto Industry: Auto and Auto Components Industry View: Positive l Result Update Downgrade on export worries Q3 FY16 results came above our expectations despite exports worries

More information

Strong operational performance

Strong operational performance ABB India Equity Research Engineering & Capital Goods February 8, 2016 Result Update Emkay Your success is our success Strong operational performance CMP Target Price Rs1,134 Rs1,407 ( ) Rating Upside

More information

Maruti Suzuki. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research Q3 results subdued, Outlook remains good; BUY January 28, 2016 Rohan Korde [email protected] +91 22 66322235 Rating BUY Price Rs4,103 Target Price Rs4,844 Implied Upside 18.1% Sensex 24,470 Nifty

More information

Flexituff International Ltd. (FIL)

Flexituff International Ltd. (FIL) s $CompanyN ame$ Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 (Wholly owned subsidiary of Bank of Baroda) Q2FY16 Result Review BUY Flexituff International Ltd. (FIL)

More information

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI $Com panyname$ Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 2QFY16 Result Review (Wholly owned subsidiary of Bank of Baroda) HOLD PI Industries Ltd. Custom synthesis

More information

Results impacted by subdued demand

Results impacted by subdued demand India Equity Research Agri Input & Chemicals January 25, 2016 Result Update Coromandel International Results impacted by subdued demand Emkay Your success is our success CMP Target Price Rs165 Rs225 (

More information

Gujarat State Petronet Ltd. INR 135

Gujarat State Petronet Ltd. INR 135 Jan-15 Mar-15 May-15 Jul-15 Sep-15 Nov-15 Jan-16 India Equity Institutional Research Oil & Gas RESULT UPDATE Gujarat State Petronet Ltd. INR 135 Growth in volumes to propel earnings Accumulate Gujarat

More information

Higher other income drive the quarter

Higher other income drive the quarter Gujarat State Petronet India Equity Research Oil & Gas February 4, 2016 Result Update Emkay Your success is our success Higher other income drive the quarter CMP Target Price Rs136 Rs163 ( ) Rating Upside

More information

Emkay. Revenues traction improves; Retain BUY HSIL. Healthy revenue performance; miss on margins

Emkay. Revenues traction improves; Retain BUY HSIL. Healthy revenue performance; miss on margins HSIL India Equity Research Others February 3, 2016 Result Update Emkay Your success is our success Revenues traction improves; Retain BUY CMP Target Price Rs271 Rs370 ( ) Rating Upside BUY ( ) 36.6 % Healthy

More information

GAIL (India) Ltd. INR 346

GAIL (India) Ltd. INR 346 Feb-15 Apr-15 Jun-15 Aug-15 Oct-15 Dec-15 Feb-16 India Equity Institutional Research Oil & Gas RESULT UPDATE GAIL (India) Ltd. INR 346 Good performance; Near term outlook looks stable BUY GAIL reported

More information

Accumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH

Accumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH Q3FY16 RESULT UPDATE GEOJIT BNP PARIBAS Research RETAIL EQUITY RESEARCH Exide Industries Ltd(EIL) Automobile Ancillaries BSE CODE: 500086 NSE CODE: EXIDEIND Bloomberg CODE: EXID IN SENSEX: 23,759 Accumulate

More information

HCC BUY. Infrastructure January 29, 2016

HCC BUY. Infrastructure January 29, 2016 Jan-15 Mar-15 Apr-15 May-15 Jul-15 Aug-15 Sep-15 Nov-15 Dec-15 Jan-16 India Research Infrastructure January 29, 2016 QUARTERLY REVIEW Bloomberg: IN Reuters: HCNS.BO BUY Better margins drive earnings s

More information

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH Q2FY16 RESULT UPDATE GEOJIT BNP PARIBAS Research RETAIL EQUITY RESEARCH SUPREME INDUSTRIES LTD Plastic Products BSE CODE:509930 NSE CODE: SUPREMEIND Bloomberg CODE: SIL IN SENSEX: 24,470 HOLD CMP Rs725

More information

Simplex Infrastructures

Simplex Infrastructures 2QFY216 Result Update Infrastructure November 17, 215 Simplex Infrastructures Performance Highlights Quarterly highlights - Standalone Y/E March (` cr) 2QFY16 1QFY16 2QFY15 % chg (yoy) % chg (qoq) Net

More information

Mangalam Cement Weak volumes marred performance

Mangalam Cement Weak volumes marred performance CMP* (Rs) 206 Market Cap. (Rs bn) 5.5 Free Float (%) 72 Shares O/S (mn) 26.7 Mangalam Cement Weak volumes marred performance Mangalam Cement (MCL) delivered a weak performance in 2Q but was marginally

More information

Minda Industries Ltd. INR 886

Minda Industries Ltd. INR 886 Jan-15 Mar-15 May-15 Jul-15 Sep-15 Nov-15 Jan-16 India Equity Institutional Research Automobiles RESULT UPDATE Minda Industries Ltd. INR 886 Profit boosted by margins ACCUMULATE In Q3FY16, Minda Industries

More information

Salzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment

Salzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment $CompanyN ame$ Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 2QFY16 Result Review (Wholly owned subsidiary of Bank of Baroda) BUY Salzer Electronics Ltd. Steady

More information

HOLD. The case of missing sales growth ZYDUS WELLNESS. Target Price: Rs 780. Q3highlights

HOLD. The case of missing sales growth ZYDUS WELLNESS. Target Price: Rs 780. Q3highlights The case of missing sales growth Zydus Q3 net sales at Rs1.1 bn was up 3% on a like-to-like basis (Q3 15 had Rs 223 mn additional excise duty credit from prior periods), below our estimate of 6%. The company

More information

BUY. Muted Q3; Brands & Retail story to unfold ARVIND. Target Price: Rs 344. Segmental highlights

BUY. Muted Q3; Brands & Retail story to unfold ARVIND. Target Price: Rs 344. Segmental highlights 05 FEB 2016 Quarterly Update BUY Target Price: Rs 344 Muted Q3; Brands & Retail story to unfold Arvind s Q3 consolidated revenue at Rs 21.6 bn (Rs 20.7 bn in Q3FY15) was marginally below our estimate of

More information

GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare Strong pricing power, Attractive valuations "BUY" February 09, 2016 Amnish Aggarwal [email protected] +91 22 66322233 Gaurav Jogani [email protected] +91 22 66322238 Rating BUY Price Rs5,837

More information

HOLD. Q4 earnings beat but order backlog flat ABB. Target Price: Rs 1,213. Key drivers

HOLD. Q4 earnings beat but order backlog flat ABB. Target Price: Rs 1,213. Key drivers 05 FEB 2016 Quarterly Update HOLD Target Price: Rs 1,213 Q4 earnings beat but order backlog flat s Q4CY15revenue at Rs24bnwasin line withour expectation of Rs24bn. EBITDA margin improved 290 bps YoYand

More information

India Equity Research Telecommunications September 2, 2015 Management Meet Update

India Equity Research Telecommunications September 2, 2015 Management Meet Update Bharti Infratel India Equity Research Telecommunications September 2, 2015 Management Meet Update Emkay Your success is our success Data demand to accelerate growth CMP Rs396 Target Price Rs505 ( ) Rating

More information

Kotak Mahindra Bank Rs 685

Kotak Mahindra Bank Rs 685 India Equity Institutional Research BANKS RESULT UPDATE Kotak Mahindra Bank Rs 685 Smooth merger; benefits to accrue HOLD KMB s consolidated PAT for Q4FY15 stood at INR 9.5 that primarily on the back of

More information

Britannia Industries

Britannia Industries Rally in Input costs near term drag, Maintain BUY June 20, 2016 Amnish Aggarwal [email protected] +91 22 66322233 Gaurav Jogani [email protected] +91 22 66322238 Rating BUY Price Rs2,641

More information

Company Overview. Financial Performance

Company Overview. Financial Performance Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 SPS Finquest Ltd CMP: 84.60 January 13, 2015 Stock Details BSE code 538402 BSE ID SPS Face value ( ) 10 No of shares

More information

The Ramco Cements. Source: Company Data; PL Research

The Ramco Cements. Source: Company Data; PL Research Robust performance; remains the best play on Southern region February 09, 2016 Kamlesh Bagmar [email protected] +91 22 66322237 Ankit Shah [email protected] +91 22 66322244 Rating BUY Price

More information

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research FY17 could be a year of revenue growth February 08, 2016 Govind Agarwal [email protected] +91 22 66322300 Rating Accumulate Price Rs440 Target Price Rs510 Implied Upside 15.9% Sensex 24,617 Nifty

More information

Techno Electric & Engineering Limited

Techno Electric & Engineering Limited Engineering & Capital Goods Event Update Techno Electric & Engineering Limited Buy Wind business spin off will lead to value unlocking. Institutional Research CMP (`) 404 Target (`) 504 Nifty: 8,224 Sensex:

More information

Navin Fluorine International

Navin Fluorine International RESULTS REVIEW 2QFY16 29 OCT 2015 Navin Fluorine International INDUSTRY CHEMICALS CMP (as on 29 Oct 2015) Rs 1,579 Target Price Rs 1,800 Nifty 8,112 Sensex 26,838 KEY STOCK DATA Bloomberg NFIL IN No. of

More information

JSW Energy Ltd. Interest expenses dragged the bottom-line BUY. Jan. 25, 2016

JSW Energy Ltd. Interest expenses dragged the bottom-line BUY. Jan. 25, 2016 JSW Energy Ltd. Interest expenses dragged the bottom-line JSW Energy Ltd. (JSWEL) reported a mixed set of numbers for Q3 FY16 quarter. The company reported a consolidated total operating income of Rs.

More information

Bharat Electronics. Strong margins, improved inflows! Source: Company Data; PL Research

Bharat Electronics. Strong margins, improved inflows! Source: Company Data; PL Research Strong margins, improved inflows! January 28, 2016 Kunal Sheth [email protected] +91 22 66322257 Samir Bendre [email protected] +91 22 66322256 Rating Accumulate Price Rs1,228 Target Price Rs1,353

More information

S.H.Kelkar &Co. Ltd. Buy. Proxy FMCG Play. Outlook & Valuation. November 16, 2015

S.H.Kelkar &Co. Ltd. Buy. Proxy FMCG Play. Outlook & Valuation. November 16, 2015 November 16, 2015 Buy S.H.Kelkar &Co. Ltd Industry: Fragrance and Flavor Industry View: Overweight Initiating Coverage Proxy FMCG Play SHK is the largest domestic fragrance manufacturer with ~ 20.5% market

More information

BUY. KELLTON TECH SOLUTIONS LTD Result Update (CONSOLIDATED): Q1 FY16. CMP 226.50 Target Price 260.00. JANUARY 9 th 2015 SYNOPSIS ISIN: INE164B01022

BUY. KELLTON TECH SOLUTIONS LTD Result Update (CONSOLIDATED): Q1 FY16. CMP 226.50 Target Price 260.00. JANUARY 9 th 2015 SYNOPSIS ISIN: INE164B01022 BUY CMP 226.50 Target Price 260.00 KELLTON TECH SOLUTIONS LTD Result Update (CONSOLIDATED): Q1 FY16 JANUARY 9 th 2015 ISIN: INE164B01022 Index Details Stock Data Sector IT Software Products BSE Code 519602

More information

Tree House Education & Accessories

Tree House Education & Accessories 2QFY2016 Result Update Educational Services November 10, 2015 Tree House Education & Accessories Performance Highlights Y/E March (` cr) 2QFY16 2QFY15 % chg (qoq) 1QFY16 % chg (yoy) Net sales 57 50 15.1

More information

Jubilant Life Sciences

Jubilant Life Sciences Radiopharma, Niacin continues to drive sales, margins October 30, 2015 Surajit Pal [email protected] +912266322259 Rating BUY Price Rs401 Target Price Rs578 Implied Upside 44.1% Sensex 26,838 Nifty

More information

BUY. Key Risks. Technology - Technology Services - Information Services. Nov 19, 2015. CRISIL Ltd. Recommendation (Rs.)

BUY. Key Risks. Technology - Technology Services - Information Services. Nov 19, 2015. CRISIL Ltd. Recommendation (Rs.) Technology - Technology Services - Information Services India Research - Stock Broking Economic recovery to boost revenues across business segments: The rating revenues witnessed 8% growth in 214 compared

More information

Just Dial Ltd Bloomberg Code: JUST IN

Just Dial Ltd Bloomberg Code: JUST IN Communications - Internet Media Oct 14, 215 Bloomberg Code: JUST IN India Research - Stock Broking India s local search engine, warming up with add-on services Just Dial is now into a platform where people

More information

HCL Technologies BUY. Performance Highlights CMP. `857 Target Price `1,132. 1QFY2016 Result Update IT. 3-year price chart

HCL Technologies BUY. Performance Highlights CMP. `857 Target Price `1,132. 1QFY2016 Result Update IT. 3-year price chart 1QFY2016 Result Update IT October 21, 2015 HCL Technologies Performance Highlights (` cr) Consl. 1QFY16 4QFY15 % chg (qoq) 1QFY15 % chg (yoy) Net revenue 10,097 9,777 3.3 8,735 15.6 EBIT 1,979 1,976 0.2

More information

UltraTech Cement Ltd.

UltraTech Cement Ltd. Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 October 31, 212 COMPANY RESULTS REPORT REVIEW UltraTech Cement Ltd. Rich valuation overlooks strong performance

More information

HOLD HEXAWARE TECHNOLOGIES. Q4 lackluster; CY16 holds promise. Target Price: Rs 252. Q4earnings concall highlights

HOLD HEXAWARE TECHNOLOGIES. Q4 lackluster; CY16 holds promise. Target Price: Rs 252. Q4earnings concall highlights 05 FEB 2016 Quarterly Update HOLD Target Price: Rs 252 Q4 lackluster; CY16 holds promise Hexaware s Q4CY15 performance was lower than our estimates. Revenue growth and margin were largely impacted due

More information

Khambatta Securities Ltd.

Khambatta Securities Ltd. Attractive Valuation Strong Buy Sector : Bank Private Target Price : Rs 284 Current Market Price : Rs 230 Market Cap : Rs 1,337 bn 52-week High/Low : Rs 393/216 Daily Avg. Volume : 13.88 mn Shares in issue

More information

BUY. Lower realization impacts earnings CAIRN INDIA. Target Price: Rs 155. Analyst call highlights

BUY. Lower realization impacts earnings CAIRN INDIA. Target Price: Rs 155. Analyst call highlights 25 JAN 2016 Quarterly Update BUY Target Price: Rs 155 Lower realization impacts earnings Despite flat QoQ oil and gas production, Cairn s Q3FY16 PAT slumped to Rs 87mn (vs. Rs 6,727 bn in Q2FY16) due to

More information

Wipro BUY. Performance Highlights CMP. `573 Target Price `719. 2QFY2016 Result Update IT. Investment Period 12 Months. 3-year price chart

Wipro BUY. Performance Highlights CMP. `573 Target Price `719. 2QFY2016 Result Update IT. Investment Period 12 Months. 3-year price chart Wipro Performance Highlights (` cr) 2QFY16 1QFY16 % chg (qoq) 2QFY15 % chg (yoy) Net revenue 12,514 12,371 1.2 11,684 7.1 EBITDA 2,729 2,606 4.7 2,482 9.9 EBITDA margin (%) 21.8 21.3 51bp 21.2 56bp PAT

More information

RamKrishna Forgings Ltd.

RamKrishna Forgings Ltd. January 3, 2014 RamKrishna Forgings Ltd. Poised for Growth CMP INR 81 Target INR 117.2 Coverage Follow Up BUY Key Share Data Face Value (INR) 10 Equity Capital (in INR Million) 211.0 Market Cap (in INR

More information

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%) BUY CMP 514.75 Target Price 590.00 DOC CODE: FOTL_090220164_3 IGARASHI MOTORS INDIA LTD Result Update (PARENT BASIS): Q3 FY16 FEBRUARY 9 th 2016 ISIN: INE188B01013 12 th h, 2013 Index Details Stock Data

More information

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%) BUY CMP 196.40 Target Price 225.00 STYLAM INDUSTRIES LIMITED Result Update (PARENT BASIS): Q2 FY16 DECEMBER 16 th. 2015 ISIN: INE239C01012 12 th h, 2013 Index Details Stock Data Sector Plastic Products

More information

Larsen & Toubro. Source: Company Data; PL Research

Larsen & Toubro. Source: Company Data; PL Research Order inflow surprise, challenges on profitability continues! January 29, 2016 Kunal Sheth [email protected] +91 22 66322257 Samir Bendre [email protected] +91 22 66322256 Rating BUY Price Rs1,102

More information

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%) BUY CMP 170.30 Target Price 196.00 GEOMETRIC LTD Result Update (CONSOLIDATED): Q2 FY16 DECEMBER 17 th 2015 ISIN: INE797A01021 12 th h, 2013 Index Details Stock Data Sector IT Consulting & Software BSE

More information

HOLD ASTRAL POLYTECHNIK. Q3 muted; recovery ahead. Target Price: Rs 377. Key highlights. Key drivers

HOLD ASTRAL POLYTECHNIK. Q3 muted; recovery ahead. Target Price: Rs 377. Key highlights. Key drivers 11 FEB 2016 Quarterly Update HOLD Target Price: Rs 377 Q3 muted; recovery ahead Astral sq3fy16 results were impacted due to: (1) adverse raw-material prices in pipe division (~Rs 80 mn), (2) closure of

More information

BUY GUJARAT STATE PETRONET. Operationally in line; other income surprises. Target Price: Rs 160. Valuations comfortable. Visible triggers ahead

BUY GUJARAT STATE PETRONET. Operationally in line; other income surprises. Target Price: Rs 160. Valuations comfortable. Visible triggers ahead 05 FEB 2016 Quarterly Update BUY Target Price: Rs 160 Operationally in line; other income surprises GSPL s Q3FY16PAT at Rs 1.2bn was higher than our estimate (Rs 1.1bn) due to higher other income at Rs

More information

CMP: 1152.10 JUNE 2016 SWARAJ ENGINES LTD

CMP: 1152.10 JUNE 2016 SWARAJ ENGINES LTD Index Details SWARAJ ENGINES LTD Result Update (PARENT BASIS): Q4 FY16 Stock Data Sector Auto Parts & Equipment BSE Code 500407 Face Value 10.00 52wk. High / Low (Rs.) 1207.90/762.00 Volume (2wk. Avg.)

More information

BUY RSWM LTD SYNOPSIS. CMP 292.20 Target Price 336.00. SEPTEMBER 1 st 2015. Result Update(PARENT BASIS): Q1 FY16

BUY RSWM LTD SYNOPSIS. CMP 292.20 Target Price 336.00. SEPTEMBER 1 st 2015. Result Update(PARENT BASIS): Q1 FY16 BUY CMP 292.20 Target Price 336.00 RSWM LTD Result Update(PARENT BASIS): Q1 FY16 SEPTEMBER 1 st 2015 ISIN: INE611A01016 Index Details Stock Data Sector Textiles BSE Code 500350 Face Value 10.00 52wk. High

More information

Pidilite Industries. Source: Company Data; PL Research

Pidilite Industries. Source: Company Data; PL Research Bountiful margin expansion in a tepid demand scenario February 03, 2016 Amnish Aggarwal [email protected] +91 22 66322233 Gaurav Jogani [email protected] +91 22 66322238 Rating Accumulate

More information

Va Tech Wabag. Source: Company Data; PL Research

Va Tech Wabag. Source: Company Data; PL Research Weak execution, guidance hints a strong Q4FY16 February 08, 2016 Nishna Biyani [email protected] +91 22 66322239 Keyur Pandya [email protected] +91 22 +91 22 66322247 Rating BUY Price Rs577

More information

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research.

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research. Sector Update Rating matrix Target price Company Old New CMP Potential Upside HEG 225 275 238 19% Graphite India 85 15 91 18% Target period 12-15 months Price performance (%) Return % 1M 3M 6M 12M HEG

More information

Granules India Ltd. INR 113

Granules India Ltd. INR 113 India Equity Institutional Research Pharma RESULT UPDATE Granules India Ltd. INR 113 Misses expectation BUY Result highlights Net sales for the quarter grew by a moderate 8% YoY to INR 3,449mn below our

More information

How To Value Hpl In India

How To Value Hpl In India Materials - Containers & Packaging Oct 01, 2015 Bloomberg Code: HPPL IN India Research - Stock Broking Backed by Acquisition, Set to Augment Market Share New acquisition: In FY15, HPPL acquired 100% of

More information

Bata India Ltd. (BIL)

Bata India Ltd. (BIL) Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Q2FY16 Result Review (Wholly owned subsidiary of Bank of Baroda) BUY Bata India Ltd. (BIL) Cloudy quarter sunshine ahead;

More information

Bharat Earth Movers (BEML)

Bharat Earth Movers (BEML) 2QFY2016 Result Update Capital Goods November 13, 2015 Bharat Earth Movers (BEML) Performance Highlights Quarterly highlights - Standalone Y/E March (` cr) 2QFY16 1QFY16 2QFY15 % chg (yoy) % chg (qoq)

More information

Coal India Ltd. Subdued e-auction realization impacted profitability BUY. Nov. 17, 2015

Coal India Ltd. Subdued e-auction realization impacted profitability BUY. Nov. 17, 2015 17-Nov-14 17-Dec-14 17-Jan-15 17-Feb-15 17-Mar-15 17-Apr-15 17-May-15 17-Jun-15 17-Jul-15 17-Aug-15 17-Sep-15 17-Oct-15 Coal India Ltd. Subdued e-auction realization impacted profitability Coal India Ltd.

More information

CD Equisearch Pvt Ltd

CD Equisearch Pvt Ltd Dec 10, 2015 Mayur Uniquoters Ltd. No. of shares (m) 46.3 Mkt cap (Rs crs/$m) 1943/291 Current price (Rs/$) 420/6.3 Price target (Rs/$) 475/7.1 52 week H/L (Rs.) 518/378 Book Value (Rs/$) 67.8/1.0 P/BV

More information

BUY. ECLERX SERVICES LIMITED (CONSOLIDATED) Result Update: Q1 FY16. CMP 1677.00 Target Price 1880.00. SEPTEMBER 2 nd, 2015 SYNOPSIS ISIN: INE738I01010

BUY. ECLERX SERVICES LIMITED (CONSOLIDATED) Result Update: Q1 FY16. CMP 1677.00 Target Price 1880.00. SEPTEMBER 2 nd, 2015 SYNOPSIS ISIN: INE738I01010 BUY CMP 1677.00 Target Price 1880.00 ECLERX SERVICES LIMITED (CONSOLIDATED) Result Update: Q1 FY16 SEPTEMBER 2 nd, 2015 ISIN: INE738I01010 Index Details Stock Data Sector IT & ITes BSE Code 532927 Face

More information

YES Bank HOLD. Not out of the woods yet; Asset quality remains a key monitorable. Institutional Equity Research. January 30, 2016. Target Price Rs788

YES Bank HOLD. Not out of the woods yet; Asset quality remains a key monitorable. Institutional Equity Research. January 30, 2016. Target Price Rs788 January 3, 216 CMP* (Rs) 748 Upside/ (Downside) 5 Market Cap. (Rs bn) 314 Free Float 78 Shares O/S (mn) 419 YES Bank Not out of the woods yet; Asset quality remains a key monitorable YES Bank reported

More information

How To Understand And Value Gsk Pharma

How To Understand And Value Gsk Pharma 2QFY2016 Result Update Pharmaceutical November 2, 2015 GlaxoSmithKline Pharma Performance Highlights Y/E Mar (` cr) 2QFY2016 1QFY2016 % chg (qoq) 2QFY2015 % chg (yoy) Net Sales 692 622 11.3 739 (6.4) Other

More information

Cipla Ltd. Rs. 741. India Equity Institutional Research Pharma. One off revenues from Nexium supply drives earnings HOLD. Target Price (Rs): 765

Cipla Ltd. Rs. 741. India Equity Institutional Research Pharma. One off revenues from Nexium supply drives earnings HOLD. Target Price (Rs): 765 India Equity Institutional Research Pharma RESULT UPDATE Cipla Ltd. Rs. 741 One off revenues from Nexium supply drives earnings HOLD Result highlights Cipla s Q1FY16 result beats our estimates due to higher

More information

Kajaria Ceramics HOLD. Robust Q2 but rich valuations downgrade to HOLD. Results Review INDIA TP: INR 875.00 4.7% KJC IN

Kajaria Ceramics HOLD. Robust Q2 but rich valuations downgrade to HOLD. Results Review INDIA TP: INR 875.00 4.7% KJC IN Results Review 21 October 2015 HOLD Robust Q2 but rich valuations downgrade to HOLD KJC s Q2FY16 revenues beat estimates, rising 13.4% YoY to Rs 5.4bn driven by volume growth of 11.9% YoY. EBITDA margins

More information

Butterfly Gandhimathi (GANAP) 188

Butterfly Gandhimathi (GANAP) 188 Result Update Rating matrix Rating : Buy Target : 240 Target Period : 12 months Potential Upside : 27% What s changed? Target EPS FY16E EPS FY17E Rating Quarterly performance Unchanged Unchanged Unchanged

More information

BUY. JYOTHY LABORATORIES LTD Result Update (CONSOLIDATED BASIS): Q2 FY16. CMP 298.00 Target Price 340.00. DECEMBER 29 th 2015.

BUY. JYOTHY LABORATORIES LTD Result Update (CONSOLIDATED BASIS): Q2 FY16. CMP 298.00 Target Price 340.00. DECEMBER 29 th 2015. BUY CMP 298.00 Target Price 340.00 JYOTHY LABORATORIES LTD Result Update (CONSOLIDATED BASIS): Q2 FY16 DECEMBER 29 th 2015 ISIN: INE668F01031 12 th h, 2013 Index Details Stock Data Sector Household Products

More information

Zee Entertainment BUY. Outlook steady; expect another strong quarter. Company Update INDIA TP: INR 465.00 9.4% Z IN

Zee Entertainment BUY. Outlook steady; expect another strong quarter. Company Update INDIA TP: INR 465.00 9.4% Z IN Company Update 6 January 2016 BUY Outlook steady; expect another strong quarter We recently interacted with ZEE s management and key highlights are: (1) Advertising revenue momentum, both domestic and

More information

Bata India BUY. Favourable base shores up Q3, BUY. Results Review INDIA TP: INR 630.00 29.3% BATA IN

Bata India BUY. Favourable base shores up Q3, BUY. Results Review INDIA TP: INR 630.00 29.3% BATA IN Results Review 10 February 2016 BUY Favourable base shores up Q3, BUY BATA posted strong Q3FY16 results with net sales/ebitda/adj. PAT growth of 15%/30.4%/27.5% YoY as SSS grew by an estimated ~11-12%

More information

Lakshmi Machine Works

Lakshmi Machine Works Results Review 3 November 2015 BUY Lakshmi Machine Works Early signs of pick up in execution, maintain BUY LMW s Q2FY16 PAT at Rs 566mn (+6% YoY) was ahead of expectations on account of higher growth in

More information

Mahindra CIE Automotive Ltd.

Mahindra CIE Automotive Ltd. Apr-14 May-14 Jun-14 Jul-14 Aug-14 Sep-14 Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15. Volume No.. 1 Issue No. 9 Automotive Ltd. April 08, 2015 BSE Code: 532756 NSE Code: MAHIND Reuters Code: MAHN.NS

More information

Quant Picks United Breweries

Quant Picks United Breweries October 6, 2015 Quant Picks United Breweries Research Analyst Amit Gupta [email protected] Raj Deepak Singh [email protected] Azeem Ahmad [email protected] i

More information

Polaris BUY. Virtusa acquires majority in Polaris. Institutional Equity Research. November 05, 2015. Target Price Rs220. IT India.

Polaris BUY. Virtusa acquires majority in Polaris. Institutional Equity Research. November 05, 2015. Target Price Rs220. IT India. CMP* (Rs) 204 Market Cap. (Rs bn) 20 Free Float (%) 71 Shares O/S (mn) 100 Polaris Virtusa acquires majority in Polaris Virtusa Corp has purchased promoter and Citi s stake in Polaris of 53% for Rs220

More information

Support CNX Nifty 8119 7951 168 2.12% S1 8023 Nifty Future 8133 7977 156 1.95% S2 8008 Prem / Disc 14 26.1 S3 7913 PCR (OI) 1.18 1.

Support CNX Nifty 8119 7951 168 2.12% S1 8023 Nifty Future 8133 7977 156 1.95% S2 8008 Prem / Disc 14 26.1 S3 7913 PCR (OI) 1.18 1. EAGLE i 06 Oct 15 5-Oct 1-Oct Chg % Chg Support CNX Nifty 8119 7951 168 2.12% S1 8023 Nifty Future 8133 7977 156 1.95% S2 8008 Prem / Disc 14 26.1 S3 7913 PCR (OI) 1.18 1.07 Pivot PCR (Vol) 1.10 0.98 8084

More information

HEG Ltd (HEG) 160. Performs well. Result Update. ICICI Securities Ltd Retail Equity Research. November 10, 2015

HEG Ltd (HEG) 160. Performs well. Result Update. ICICI Securities Ltd Retail Equity Research. November 10, 2015 Result Update Rating matrix Rating : Hold Target : 175 Target Period : 12 months Potential Upside : 9% What s Changed? Target Changed from 185 to 175 EPS FY16E Unchanged from 9.1 to 9.5 EPS FY17E Unchanged

More information

Smruthi Organics Limited BSE Scrip Code: 590046

Smruthi Organics Limited BSE Scrip Code: 590046 Smruthi Organics Limited BSE Scrip Code: 590046 Pharmaceuticals September 21, 2012 Equity Statistics Current Market Price Rs. 218.1 52 Week High / Low Rs. 273.9 / 155 Market Capitalisation Rs. crores 83.2

More information

Shriram Transport Finance Subsidiaries witness sharp increase in NPA

Shriram Transport Finance Subsidiaries witness sharp increase in NPA Shriram Transport Finance Subsidiaries witness sharp increase in NPA Shriram Transport Finance s (STFC) standalone performance was broadly in-line with our expectation but grossly disappointed on asset

More information

Maruti Suzuki India (MARUTI) 4095

Maruti Suzuki India (MARUTI) 4095 Result Update Rating matrix Rating : Buy Target : 4940 Target Period : 12 months Potential Upside : 21% What s Changed? Target Changed from 5090 to 4940 EPS FY16E Changed from 178.3 to 168.9 EPS FY17E

More information

East India Hotels (EIH) Ltd Growing Strategically

East India Hotels (EIH) Ltd Growing Strategically East India Hotels (EIH) Ltd Growing Strategically BSE Code 500840 NSE Code EIHOTEL Bloomberg Code EIH@IN Face Value 10 CMP Rs 224 Market Cap Rs 11.7bn (as on August 27th 2004) Share Holding Pattern Others

More information

BDI BioEnergy Intern. 20.0 Neutral. Activity level in Q3 might not support FY estimates

BDI BioEnergy Intern. 20.0 Neutral. Activity level in Q3 might not support FY estimates 8/11/1 8/1/11 8/3/11 8/5/11 8/7/11 8/9/11 8/11/11 8/1/12 8/3/12 8/5/12 8/7/12 8/9/12 MATELAN Research Preview Note Price as of 9/11/12: 8.69 12 November 212 Company / Sector Fair Value Recommendation BDI

More information

SAIL (SAIL) 56. Dismal performance. Result Update. ICICI Securities Ltd Retail Equity Research. August 17, 2015

SAIL (SAIL) 56. Dismal performance. Result Update. ICICI Securities Ltd Retail Equity Research. August 17, 2015 Result Update Rating matrix Rating : Sell Target : 50 Target Period : 12 months Potential Upside : -11% What s Changed? Target Changed from 60 to 50 EPS FY16E Changed from 4.8 to 1.1 EPS FY17E Changed

More information

Eicher Motors BUY. RE margins beat estimates; volume visibility high. Results Review INDIA TP: INR 22,300.00 23.1% EIM IN

Eicher Motors BUY. RE margins beat estimates; volume visibility high. Results Review INDIA TP: INR 22,300.00 23.1% EIM IN Results Review 5 February 2016 BUY RE margins beat estimates; volume visibility high EIM reported above-expected RE margins of 28.6% (RCMLe 27.5%) for Q4CY15 helped by a 250bps drop in RM costs, with PAT

More information

Axis Bank. Strong core performance. Source: Company Data; PL Research

Axis Bank. Strong core performance. Source: Company Data; PL Research Strong core performance January 17, 2011 Abhijit Majumder [email protected] +91 22 66322236 Umang Shah [email protected] +91 22 66322242 Rating BUY Price Rs1,230 Target Price Rs1,600 Implied

More information

SJVN BUY. Robust performance continues, reiterate BUY. Results Review INDIA TP: INR 35.00 27.5% SJVN IN

SJVN BUY. Robust performance continues, reiterate BUY. Results Review INDIA TP: INR 35.00 27.5% SJVN IN Results Review 10 November 2015 BUY IN Robust performance continues, reiterate BUY reported strong Q2FY16 results with core ROE of 8.6%, above our expectations. Core PAT for the quarter grew 13% YoY to

More information

RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS. Earnings Presentation Q2 FY16

RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS. Earnings Presentation Q2 FY16 RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS Earnings Presentation Q2 FY16 Company Overview COMPANY OVERVIEW Rajesh Exports Ltd. (REL) was incorporated in 1989. Currently REL is a leader

More information

Kingdee (268 HK) Buy (maintained) Target price: HK$3.58. Solidifying leadership in cloud services; maintain Buy but revise TP down to HK$3.

Kingdee (268 HK) Buy (maintained) Target price: HK$3.58. Solidifying leadership in cloud services; maintain Buy but revise TP down to HK$3. Equity Research Information Technology Aug 2, 21 Kingdee (28 HK) Buy (maintained) Target price: HK$.8 Solidifying leadership in cloud services; maintain Buy but revise TP down to HK$.8 Lower-than-expected

More information

Cipla Ltd. INR 542. India Equity Institutional Research Pharma. Muted quarter; outlook remains robust. Target Price (INR): 646. Potential Upside : 19%

Cipla Ltd. INR 542. India Equity Institutional Research Pharma. Muted quarter; outlook remains robust. Target Price (INR): 646. Potential Upside : 19% India Equity Institutional Research Pharma RESULT UPDATE Cipla Ltd. INR 542 Muted quarter; outlook remains robust BUY Result highlights Cipla s Q3FY16 Net Sales, EBITDA and PAT were below our estimates.

More information